orforglipron vs retatrutide Foundayo (Orforglipron): Injection or Pill? Orforglipron vs Zepbound: A Realistic

Anand warns

And we can see the big picture of how the treatment decisions we make today can ripple across a patients future health

Your provider will determine your starting point, adjust doses based on your response, and guide you to an effective maintenance dose

Social media is full of before-and-after stories, transformation photos, and testimonials about how these treatments are reshaping lives

On April 17, Eli Lilly announced that its drug orforglipron became the first oral GLP-1 to successfully complete a Phase 3 trial for safety and efficacy for people with diabetes and obesity

The current controversy is whether or not GLP-1 receptor agonists need to be discontinued prior to endoscopic procedures to minimize aspiration risk during monitored anesthesia care